Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.20.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Revenues:    
Total revenues $ 33,161 $ 43,484
Operating costs and expenses:    
Cost of Captisol 4,683 3,858
Amortization of intangibles 3,535 3,503
Research and development 11,891 11,289
General and administrative 9,264 11,088
Total operating costs and expenses 29,373 29,738
Gain from sale of Promacta license 0 812,797
Income from operations 3,788 826,543
Other income (expense):    
Gain (loss) from Viking (25,457) 17,293
Interest income 4,730 5,909
Interest expense (8,548) (8,906)
Other expense, net (4,928) 1,874
Total other income (loss), net (34,203) 16,170
Income (loss) before income taxes (30,415) 842,713
Income tax benefit (expense) 6,284 (176,376)
Net income (loss) $ (24,131) $ 666,337
Earnings Per Share, Basic and Diluted:    
Basic net income (loss) per share (USD per share) $ (1.46) $ 32.59
Shares used in basic per share calculations (shares) 16,529 20,447
Diluted net income (loss) per share (USD per share) $ (1.46) $ 31.32
Shares used in diluted per share calculations (shares) 16,529 21,277
Royalties    
Revenues:    
Total revenues $ 6,565 $ 19,538
Captisol    
Revenues:    
Total revenues 21,109 8,959
Service revenue    
Revenues:    
Total revenues 3,357 3,883
Contract revenue    
Revenues:    
Total revenues $ 2,130 $ 11,104